Induction of apoptosis or necrosis in human endometrial carcinoma cells by 2-methoxyestradiol

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 3983-3990

  Li, Li ^a,c   Heldin, Nils Erik ^b   Grawé, Jan ^b   Ulmsten, Ulf ^a   Fu, Xin ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

2 Methoxyestradiol; Apoptosis; Caspases; Cell cycle; Endometrium carcinoma cells; HEC 1 A; iNOS; Necrosis; RL 95 2; STAT1

Indexed keywords

2 METHOXYESTRADIOL; ACRIDINE ORANGE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; DNA FRAGMENT; INDUCIBLE NITRIC OXIDE SYNTHASE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE SYNTHASE INHIBITOR; STAT1 PROTEIN; UNCLASSIFIED DRUG; 2-METHOXYESTRADIOL; DNA BINDING PROTEIN; DRUG DERIVATIVE; ESTRADIOL; NITRIC OXIDE SYNTHASE; NOS2A PROTEIN, HUMAN; STAT1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ADULT; BIOSYNTHESIS; CELL CYCLE; CELL GROWTH; CELL MEMBRANE POTENTIAL; CYTOLOGY; DRUG EFFECT; ENDOMETRIUM; ENDOMETRIUM TUMOR; FEMALE; INTRACELLULAR MEMBRANE; METABOLISM; MIDDLE AGED; MITOCHONDRION; NECROSIS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

ADULT; APOPTOSIS; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTRADIOL; FEMALE; FLOW CYTOMETRY; HUMANS; INTRACELLULAR MEMBRANES; MEMBRANE POTENTIALS; MIDDLE AGED; MITOCHONDRIA; NECROSIS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 14944379628     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. American Cancer Society: Cancer facts and figures 2002. Available from URL: http://www.cancer.org/downloads/ STT/CancerFacts&Figures2002TM.pdf.
2. Elit L and Hirte H: Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer. Curr Opin Obstet Gynecol 14: 67-73, 2002.
3. Mukhopadhyay T and Roth JA: Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene 23: 379-384, 1997.
4. Schumacher G, Kataoka M, Roth JA and Mukhopadhyay T: Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines. Clin Cancer Res 5: 493-499, 1999.
5. Lin HL, Liu TY, Chau GY, Lui WY and Chi CW: Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 89: 983-994, 2000.
6. Seegers JC, Aveling ML, Van Aswegen CH, Cross M, Koch F and Joubert WS: The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. J Steroid Biochem 32: 797-809, 1989.
7. Lottering ML, Haag M and Seegers JC: Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res 52: 5926-5932, 1992.
8. D'Amato RJ, Lin CM, Flynn E, Folkman J and Hamel E: 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91: 3964-3968, 1994.
9. Attalla H, Makela TP, Adlercreutz H and Andersson LC: 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem Biophys Res Commun 228: 467-473, 1996.
10. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP and Schweigerer L: The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368: 237-239, 1994.
11. Klauber N, Parangi S, Flynn E, Hamel E and D'Amato RJ: Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57: 81-86, 1997.
12. Arbiser JL, Panigrathy D, Klauber N, Rupnick M, Flynn E, Udagawa T and D'Amato RJ: The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice. J Am Acad Dermatol 40: 925-929, 1999.
13. Kataoka M, Schumacher G, Cristiano RJ, Atkinson EN, Roth JA and Mukhopadhyay T: An agent that increases tumor suppressor transgene product coupled with systemic transgene delivery inhibits growth of metastatic lung cancer in vivo. Cancer Res 58: 4761-4765, 1998.
14. Seegers JC, Lottering ML, Grobler CJ, van Papendorp DH, Habbersett RC, Shou Y and Lehnert BE: The mammalian metabolite, 2-methoxyestradiol, affects p53 levels and apoptosis induction in transformed cells but not in normal cells. J Steroid Biochem Mol Biol 62: 253-267, 1997.
15. Vindelov LL, Christensen IJ and Nissen NI: A detergent - trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327, 1983.
16. Varani J, Dame MK, Taylor CG et al: Age-dependent injury in human umbilical vein endothelial cells: relationship to apoptosis and correlation with a lack of A20 expression. Lab Invest 73: 851-858, 1995.
17. Hamel E, Lin CM, Flynn E and D'Amato RJ: Interactions of 2-Methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers. Biochemistry 35: 1304-1310, 1996.
18. Attalla H, Westberg JA, Andersson LC, Adlercreutz H and Makela TP: 2-Methoxyestradiol-induced phosphorylation of Bcl-2: uncoupling from JNK/SAPK activation. Biochem Biophys Res Commun 29: 616-619, 1998.
19. Zoubine MN, Weston AP, Johnson DC, Campbell DR and Banerjee SK: 2-Methoxyestradiol-induced growth suppression and lethality in estrogen-responsive MCF-7 cells may be mediated by down regulation of p34cdc2 and cyclin B1 expression. Int J Oncol 15: 639-646, 1999.
20. Kumar AP, Garcia GE and Slaga TJ: 2-Methoxyestradiol blocks cell-cycle progression at G(2)/M phase and inhibits growth of human prostate cancer cells. Mol Carcinog 31: 111-124, 2001.
21. Qadan LR, Perez-Stable CM, Anderson C, D'Ippolito G, Herron A, Howard GA and Roos BA: 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer. Biochem Biophys Res Commun 285: 1259-1266, 2001.
22. Kroemer G, Dallaporta B and Resche-Rigon M: The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60: 619-642, 1998.
23. Boyle JJ, Weissberg PL and Bennett MR: Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas/Fas-L interactions. Arterioscler Thromb Vase Biol 22: 1624-1630, 2002.
24. Ghatan S, Larner S and Kinoshita Y et al: p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol 150: 335-347, 2000.
25. Slomiany BL and Slomiany A: Nitric oxide interferes with salivary mucin synthesis: involvement of ERK and p38 mitogen-activated protein kinase. J Physiol Pharmacol 53: 325-336, 2002.
26. Moriya R, Uehara T and Nomura Y: Mechanism of nitric oxide-induced apoptosis in human neuroblastoma SH-SY5Y cells. FEBS Lett 484: 253-260, 2000.
27. Beuneu C, Auger R and Loffler M et al: Indirect inhibition of mitochondria dihydroorotate dehydrogenase activity by nitric oxide. Free Radic Biol Med 28: 1206-1213, 2000.
28. Li CQ, Trudel LJ and Wogan GN: Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53. Proc Natl Acad Sci USA 99: 10364-10369, 2002.
29. Xu X, Fu XY, Plate J and Chong AS: IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res 58: 2832-2837, 1998.
30. Lee KY, Anderson E, Madani K and Rosen GD: Loss of STAT1 expression confers resistance to IFN-gamma-induced apoptosis in ME180 cells. FEBS Lett 459: 323-326, 1999.
31. Huang YQ, Li JJ and Karpatkin S: Thrombin inhibits tumor cell growth in association with up-regulation of p21(waf/cip1) and caspases via a p53-independent, STAT-1-dependent pathway. J Biol Chem 275: 6462-6468, 2000.
32. Chin YE, Kitagawa M, Kuida K, Flavell RA and Fu XY: Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 17: 5328-5337, 1997.
33. Fulda S and Debatin KM. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 21: 2295-2308, 2002.
34. Rojas M, Olivier M and Garcia LF: Activation of JAK2/STAT1-alpha- dependent signaling events during Mycobacterium tuberculosis-induced macrophage apoptosis. Cell Immunol 217: 58-66, 2002.
35. Bu S, Blaukat A, Fu X, Heldin NE and Landstrom M: Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett 531: 141-151, 2002.
36. Huang YQ, Li JJ and Karpatkin S: Thrombin inhibits tumor cell growth in association with up-regulation of p21(waf/cip1) and caspases via a p53-independent, STAT-1-dependent pathway. J Biol Chem 275: 6462-6468, 2000.
37. Maran A, Zhang M, Kennedy AM, Sibonga JD, Rickard DJ, Spelsberg TC and Turner RT: 2-Methoxyestradiol induces interferon gene expression and apoptosis in osteosarcoma cells. Bone 30: 393-398, 2002.
38. Darnell JE Jr, Kerr IM and Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421, 1994.